MarketCap
Immutep Limited IMMP
€ 2.40
-7.85%
Facebook
X
Telegram
Immutep Limited DSO | IMMP
DSO Jährlich Immutep Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 351 | - | - | - | 191 | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 351 | 191 | 271 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Brickell Biotech
BBI
|
26 | - | -5.38 % | $ 6.06 M |  USA |
 |
Generation Bio Co.
GBIO
|
47.6 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
107 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
18.6 | - | - | $ 5.78 B |  Niderland |
 |
Alnylam Pharmaceuticals
ALNY
|
43.3 | $ 156.5 | -2.85 % | $ 20.5 B | USA |
 |
Amgen
AMGN
|
81.2 | $ 462.71 | -3.3 % | $ 249 B | USA |
 |
Theratechnologies
THTX
|
82.9 | - | - | $ 83.9 M |  Canada |
 |
Iovance Biotherapeutics
IOVA
|
105 | $ 7.72 | -11.26 % | $ 2.76 M | USA |
 |
Biogen
BIIB
|
50.7 | $ 243.85 | -4.17 % | $ 35.7 B | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
492 | $ 4.03 | 6.9 % | $ 652 M | USA |
 |
Armata Pharmaceuticals
ARMP
|
249 | $ 3.01 | -4.14 % | $ 109 M | USA |
 |
MannKind Corporation
MNKD
|
26.2 | $ 3.77 | -4.07 % | $ 1.15 B | USA |
 |
Insmed Incorporated
INSM
|
58 | $ 108.79 | -1.1 % | $ 21.7 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
81.3 | - | -3.76 % | $ 3.47 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
66.2 | $ 227.25 | -3.16 % | $ 13.9 B |  Irlanda |
 |
Bristol-Myers Squibb Company
BMY
|
83.9 | $ 63.15 | -1.64 % | $ 128 B | USA |
 |
Johnson & Johnson
JNJ
|
62 | $ 272.47 | -1.4 % | $ 656 B | USA |
 |
Kala Pharmaceuticals
KALA
|
729 | $ 0.15 | -13.14 % | $ 1.22 M | USA |
 |
Prothena Corporation plc
PRTA
|
6.97 | $ 7.9 | -5.84 % | $ 425 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
120 | $ 14.53 | -1.63 % | $ 12.1 B |  India |
 |
Keros Therapeutics
KROS
|
4.72 | $ 9.42 | -13.02 % | $ 351 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
211 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Kazia Therapeutics Limited
KZIA
|
28.7 | $ 7.13 | -11.76 % | $ 109 M |  Australia |
 |
Lineage Cell Therapeutics
LCTX
|
19.2 | $ 0.98 | -4.85 % | $ 226 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
66.7 | $ 298.8 | -5.48 % | $ 5.78 B | USA |
 |
Longeveron
LGVN
|
28.6 | $ 1.76 | -1.12 % | $ 30.9 B | USA |
 |
Eli Lilly and Company
LLY
|
80.5 | $ 1 366.97 | -3.62 % | $ 1.23 T | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
2.33 | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
114 | - | - | $ 521 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
11.6 | $ 4.01 | -5.2 % | $ 48.9 M |  Israel |
 |
Compugen Ltd.
CGEN
|
400 | $ 1.94 | -4.68 % | $ 181 M | Israel |
 |
Liquidia Corporation
LQDA
|
65.5 | $ 44.46 | -6.16 % | $ 3.83 B | USA |
 |
Sarepta Therapeutics
SRPT
|
412 | $ 17.5 | -7.77 % | $ 1.75 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
56.5 | - | - | $ 2.02 B | USA |
 |
Mesoblast Limited
MESO
|
0.00568 | $ 14.08 | -1.47 % | $ 17 B | Australia |